BioSpace News Archive

Drug Development

Cidara Therapeutics Announces Promising Interim Phase 2a Data Assessing the Safety and Efficacy of a Single Dose of CD388 in an Influenza Challenge Model

Cidara Therapeutics, Inc. today announced promising efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388 against the H3N2 influenza A virus strain, as of a February 13, 2023 data cut-off.

March 1, 2023
·
6 min read
Biotech Beach

Tyra Biosciences Expands Development of TYRA-300, an Oral FGFR3 Selective Agent, into Achondroplasia

Tyra Biosciences, Inc. today announced that it is expanding development of TYRA-300 into achondroplasia (ACH) based on positive preclinical results demonstrated in a study performed in collaboration with the Imagine Institute in Paris, France.

March 1, 2023
·
8 min read
BioMidwest

Bio-Techne Announces Investment in Wilson Wolf

Bio-Techne Corporation announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization target of $55 million, triggering Bio-Techne’s initial investment in the company, which is expected to close at the end of March 2023.

March 1, 2023
·
4 min read
Evogene to Attend the Annual ROTH Investor Conference in California on March 13, 2023

Evogene Ltd. today announced that it will attend and meeting with investors at the 35th Annual ROTH Conference being held in Dana Point, California on March 13-14, 2023.

March 1, 2023
·
2 min read
Pharm Country

Generian Pharmaceuticals to Participate in the Cowen 43rd Annual Healthcare Conference

Generian Pharmaceuticals, Inc. , today announced that Hank Safferstein , Chief Executive Officer of Generian Pharmaceuticals, will host investor meetings at the Cowen 43rd Annual Healthcare Conference in Boston, MA, on Tuesday, March 7, 2023.

March 1, 2023
·
1 min read
Biotech Beach

Paragon Genomics Partners with Devyser to Expand CleanPlex® Technology Distribution in Italy

Paragon Genomics announced a partnership with Devyser, a world leader in diagnostic kits and solutions for advanced DNA testing, to distribute its CleanPlex® products and technology in Italy, with the option to expand into additional territories.

March 1, 2023
·
3 min read
BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference

BELLUS Health Inc. today announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in the Respiratory/Infections panel discussion at the Cowen 43rd Annual Health Care Conference, being held March 6 - 8, 2023 in Boston, MA.

March 1, 2023
·
6 min read
Genetown

PureTech to Present at the Barclays Global Healthcare Conference - March 1, 2023

PureTech Health plc today announced that Bharatt Chowrira, Ph.D., J.D., President and Chief Business, Finance and Operating Officer, and Eric Elenko, Ph.D., Chief Innovation and Strategy Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14th, at 4:05pm EDT.

March 1, 2023
·
3 min read
Drug Development

Deciphera Pharmaceuticals Announces Completion of Enrollment for Pivotal Phase 3 MOTION Study of Vimseltinib in TGCT

Deciphera Pharmaceuticals, Inc. today announced the completion of enrollment in the pivotal Phase 3 MOTION study of vimseltinib in patients with tenosynovial giant cell tumor (TGCT) not amenable to surgery. Deciphera expects to report top-line results in the fourth quarter of 2023.

March 1, 2023
·
6 min read
ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the Cowen 43rd Annual Health Care Conference in Boston, MA, on Tuesday, March 7th at 2:50 p.m. ET.

March 1, 2023
·
4 min read